small molecular inhibitor iwp-2 Search Results


97
Tocris molecule wnt inhibitor iwp2
The hiPSCs were cultured as a monolayer on matrigel-coated plates for 2 days under pluripotent conditions and on day 0 exposed to GSK3 inhibitor, CHIR (10 µM) for 24 h. After 48 h exposed to <t>Wnt</t> inhibitor, <t>IWP2</t> (5 µM). Spontaneously beating cardiac clusters were observed from day 9 onwards. Simultaneously, cells were exposed to test substances for a single exposure of 24 h (day1). The cells were harvested for gene array analysis on day1, day4 and day14 (Fig. ). Medium changes were done as indicated every alternate date. A Representative phase-contrast images of control and ISO treated hiPSC at day1-, 4 -and 14day. Scale bar, 100 µm. B PCA blot of 54,675 probe sets for three timepoints during the differentiation. C PCA blot of the 500 SPS with the highest variance across the mean of the condition‐wise samples. The respective day is indicated by the shape and the respective measured compound is indicated by the color of the dot, as labels are shown next to the plots. The distribution of the data points on the x-axis is given by the PC 1 and on the y-axis by PC2. The percentages in parentheses denote the proportion of explained variance for the respective PC.
Molecule Wnt Inhibitor Iwp2, supplied by Tocris, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecule wnt inhibitor iwp2/product/Tocris
Average 97 stars, based on 1 article reviews
molecule wnt inhibitor iwp2 - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

92
TargetMol iwp 2
The hiPSCs were cultured as a monolayer on matrigel-coated plates for 2 days under pluripotent conditions and on day 0 exposed to GSK3 inhibitor, CHIR (10 µM) for 24 h. After 48 h exposed to <t>Wnt</t> inhibitor, <t>IWP2</t> (5 µM). Spontaneously beating cardiac clusters were observed from day 9 onwards. Simultaneously, cells were exposed to test substances for a single exposure of 24 h (day1). The cells were harvested for gene array analysis on day1, day4 and day14 (Fig. ). Medium changes were done as indicated every alternate date. A Representative phase-contrast images of control and ISO treated hiPSC at day1-, 4 -and 14day. Scale bar, 100 µm. B PCA blot of 54,675 probe sets for three timepoints during the differentiation. C PCA blot of the 500 SPS with the highest variance across the mean of the condition‐wise samples. The respective day is indicated by the shape and the respective measured compound is indicated by the color of the dot, as labels are shown next to the plots. The distribution of the data points on the x-axis is given by the PC 1 and on the y-axis by PC2. The percentages in parentheses denote the proportion of explained variance for the respective PC.
Iwp 2, supplied by TargetMol, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp 2/product/TargetMol
Average 92 stars, based on 1 article reviews
iwp 2 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

96
Selleck Chemicals small molecule inhibitors iwp2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Small Molecule Inhibitors Iwp2, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule inhibitors iwp2/product/Selleck Chemicals
Average 96 stars, based on 1 article reviews
small molecule inhibitors iwp2 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Biogems International iwp2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwp2, supplied by Biogems International, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp2/product/Biogems International
Average 93 stars, based on 1 article reviews
iwp2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Millipore iwp-2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwp 2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp-2/product/Millipore
Average 90 stars, based on 1 article reviews
iwp-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
FUJIFILM chemical compound iwp-2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Chemical Compound Iwp 2, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chemical compound iwp-2/product/FUJIFILM
Average 90 stars, based on 1 article reviews
chemical compound iwp-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
MedChemExpress iwp-2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwp 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp-2/product/MedChemExpress
Average 95 stars, based on 1 article reviews
iwp-2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
ReproCELL iwp-2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwp 2, supplied by ReproCELL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp-2/product/ReproCELL
Average 90 stars, based on 1 article reviews
iwp-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Merck KGaA iwp-2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwp 2, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp-2/product/Merck KGaA
Average 90 stars, based on 1 article reviews
iwp-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Beyotime iwp-2, an inhibitor of the wnt/β-catenin pathway
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwp 2, An Inhibitor Of The Wnt/β Catenin Pathway, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp-2, an inhibitor of the wnt/β-catenin pathway/product/Beyotime
Average 90 stars, based on 1 article reviews
iwp-2, an inhibitor of the wnt/β-catenin pathway - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
StemRD Inc iwp-2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwp 2, supplied by StemRD Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwp-2/product/StemRD Inc
Average 90 stars, based on 1 article reviews
iwp-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore iwr-1 iwp-2
Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor <t>IWP2</t> treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.
Iwr 1 Iwp 2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iwr-1 iwp-2/product/Millipore
Average 90 stars, based on 1 article reviews
iwr-1 iwp-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


The hiPSCs were cultured as a monolayer on matrigel-coated plates for 2 days under pluripotent conditions and on day 0 exposed to GSK3 inhibitor, CHIR (10 µM) for 24 h. After 48 h exposed to Wnt inhibitor, IWP2 (5 µM). Spontaneously beating cardiac clusters were observed from day 9 onwards. Simultaneously, cells were exposed to test substances for a single exposure of 24 h (day1). The cells were harvested for gene array analysis on day1, day4 and day14 (Fig. ). Medium changes were done as indicated every alternate date. A Representative phase-contrast images of control and ISO treated hiPSC at day1-, 4 -and 14day. Scale bar, 100 µm. B PCA blot of 54,675 probe sets for three timepoints during the differentiation. C PCA blot of the 500 SPS with the highest variance across the mean of the condition‐wise samples. The respective day is indicated by the shape and the respective measured compound is indicated by the color of the dot, as labels are shown next to the plots. The distribution of the data points on the x-axis is given by the PC 1 and on the y-axis by PC2. The percentages in parentheses denote the proportion of explained variance for the respective PC.

Journal: Cell Death Discovery

Article Title: Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells

doi: 10.1038/s41420-023-01616-6

Figure Lengend Snippet: The hiPSCs were cultured as a monolayer on matrigel-coated plates for 2 days under pluripotent conditions and on day 0 exposed to GSK3 inhibitor, CHIR (10 µM) for 24 h. After 48 h exposed to Wnt inhibitor, IWP2 (5 µM). Spontaneously beating cardiac clusters were observed from day 9 onwards. Simultaneously, cells were exposed to test substances for a single exposure of 24 h (day1). The cells were harvested for gene array analysis on day1, day4 and day14 (Fig. ). Medium changes were done as indicated every alternate date. A Representative phase-contrast images of control and ISO treated hiPSC at day1-, 4 -and 14day. Scale bar, 100 µm. B PCA blot of 54,675 probe sets for three timepoints during the differentiation. C PCA blot of the 500 SPS with the highest variance across the mean of the condition‐wise samples. The respective day is indicated by the shape and the respective measured compound is indicated by the color of the dot, as labels are shown next to the plots. The distribution of the data points on the x-axis is given by the PC 1 and on the y-axis by PC2. The percentages in parentheses denote the proportion of explained variance for the respective PC.

Article Snippet: The medium was then changed to basal RPMI/B-27-ins medium and cells were kept for further 24 h. At day 2, RPMI/B-27-ins medium with small molecule WNT inhibitor IWP2 (Tocris, United Kingdom) 5 μM was added and cells were kept for 48 h (day 2 to day4).

Techniques: Cell Culture, Control

Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor IWP2 treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.

Journal: National Science Review

Article Title: Inhibition of Wnt activity improves peri-implantation development of somatic cell nuclear transfer embryos

doi: 10.1093/nsr/nwad173

Figure Lengend Snippet: Wnt inhibition greatly improves the development of SCNT embryos. (a) Comparison of Wnt-related genes in differential gene expression profiles of the ICM of IVF and SCNT blastocysts. The genes marked are Wnt antagonists or activators. (b) TCF/Lef: H2B-GFP IVF (left) and SCNT (right) embryos at late E4.5 stained for GFP, Oct4, Gata6 and DAPI. Scale bar, 20 μm. (c) Percentage of GFP-positive cells in the EPI of IVF and SCNT embryos. (d) Percentage of rosette-like SCNT embryos generated with no treatment, Wnt activator CHIR treatment and Wnt inhibitor IWP2 treatment. (e) Comparison of pluripotent marker gene expression among the IVF-, SCNT- and Wnti-treated SCNT embryos. (f) Absolute value comparison of the relative expression of markers in (d) to late-E4.5 IVF EPI between groups of IVF-, SCNT- and Wnti-SCNT embryos. P -values were determined using the Wilcoxon signed-rank test. (g) GSEA of specific genes expressed in naïve and primed ESCs between the late-E4.5 EPI of untreated and Wnti-SCNT embryos. NES, normalized enrichment score. (h) PCA comparison of gene expression profiles among the late-E4.5 EPI of IVF-, SCNT- and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. Published transcriptome data of stem cell lines were obtained from GSE145727. (i) Hierarchical clustering analysis of the late-E4.5 EPI of IVF, untreated and Wnti-SCNT embryos, naïve ESCs, primed ESCs and RSCs. (j) PCA plot of E3.5 ICM, E5.5 EPI, E6.5 EPI, late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos based on the H3K27me3 levels. (k) Heat map showing the H3K27me3 levels for the naïve and primed markers between late-E4.5 EPI of IVF, SCNT and Wnti-SCNT embryos. For (c) and (d), P -values were determined using the unpaired two-tailed t -test; error bars and means ± SD are shown for n ≥ 3 experiments.

Article Snippet: Small-molecule inhibitors IWP2 (Selleck, 686770-61-6), IWR1-endo (Selleck, 1127442-82-3) and Wnt activator CHIR99021 (Sigma, SML1046) were applied to inhibit or activate the canonical Wnt/β-catenin signaling pathway.

Techniques: Inhibition, Comparison, Gene Expression, Staining, Generated, Marker, Expressing, Two Tailed Test